Cheryl McAlpine
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
-
- Immunotherapy and Immune Responses
Papers in ⓘ
-
- Immunotherapy and Immune Responses 8
-
- Cancer Research and Treatments 3
- Co-authors
- Mark R. Middleton (3 shared papers)Alexander N. Shoushtari (3 shared papers)Jeffrey R. Infante (3 shared papers)Neil Steven (3 shared papers)Omid Hamid (3 shared papers)Mario Sznol (3 shared papers)Pippa Corrie (3 shared papers)Antonella Vardeu (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Clinical Cancer Research (1 paper)Investigative Ophthalmology & Visual Science (1 paper)Journal of Neurology Neurosurgery & Psychiatry (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Cheryl McAlpine
12 papers receiving 239 citations
Peers
Comparison fields: 5 of 38
- Ophthalmology 107
- Immunology 154
- Oncology 145
- Radiology, Nuclear Medicine and Imaging 56
- Hematology 12
Countries citing papers authored by Cheryl McAlpine
This map shows the geographic impact of Cheryl McAlpine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl McAlpine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl McAlpine more than expected).
Fields of papers citing papers by Cheryl McAlpine
This network shows the impact of papers produced by Cheryl McAlpine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl McAlpine. The network helps show where Cheryl McAlpine may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheryl McAlpine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 165 | |
| 2 | 2016 | 37 | |
| 3 | 2017 | 16 | |
| 4 | G-protein-coupled receptor heterodimerization: assay technologies to clinical significance. | 2007 | 13 |
| 5 | 2023 | 8 | |
| 6 | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma | 2017 | 5 |
| 7 | 2021 | 3 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 1976 | 1 | |
| 12 | 2019 | 1 |
About Cheryl McAlpine
Cheryl McAlpine is a scholar working on Immunology, Biotechnology, Oncology, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 254 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Research and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ocular Oncology and Treatments (2 papers), Click Chemistry and Applications (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Ophthalmology (107 citations), Immunology (154 citations), Oncology (145 citations), Radiology, Nuclear Medicine and Imaging (56 citations) and Hematology (12 citations). Cheryl McAlpine has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mark R. Middleton, Alexander N. Shoushtari, Jeffrey R. Infante, Neil Steven, Omid Hamid, Mario Sznol, Pippa Corrie, Antonella Vardeu, Jacob Hurst and Victoria K. Woodcock. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigative Ophthalmology & Visual Science, Journal of Neurology Neurosurgery & Psychiatry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.